School of Medicine
Showing 1-9 of 9 Results
-
Samantha Reyes
Life Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
BioResearch Interests: Preclinical and clinical PET imaging, novel tracer validation in vivo, B cell role in multiple sclerosis and pharmacokinetic modelling
Samantha is a multidisciplinary research assistant with extensive experience in multi-modal molecular imaging of neurological diseases and a strong background in synthetic chemistry. She helped validate both a novel sigma-1 radiotracer, [18F]FTC-146, for its ability to detect molecular markers of neuropathic pain non-invasively and a [64Cu]hCD19-mAb radiotracer for imaging therapy-induced B cell depletion. Currently, her research focuses on evaluating novel therapeutics and Positron Emission Tomography (PET) imaging agents in rodent models with the ultimate goal of clinically translating these approaches and enhancing our ability to monitor and treat neurological diseases. She is well-versed in pharmacokinetic modeling, receptor occupancy studies, autoradiography, and cell-based assays. Moreover, is an expert in PET/MR imaging of neonatal mice. -
Raheleh Roudi
Basic Life Research Scientist, Rad/Molecular Imaging Program at Stanford
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers.
